JPM
JPMorgan Chase & Co.
JPM has a slight edge over PFBC overall, supported by stronger modeled upside and stronger fundamentals.
PFBC
Preferred Bank
PFBC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PFBC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
PFBC's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PFBC.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
PFBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $76.02 | -27% |
| Fair | 9.2x | $101 | -2.4% |
| Forward | 9.2x | $103 | — |
| Current | 9.5x | $103 | — |
| Expensive | 12x | $131 | +26% |
Historical ranges are pointers, not guarantees.
PFBC has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
PFBC Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PFBC, with profitability improving.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over PFBC on earnings, with more consistent year-over-year improvement.
PFBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.25 | +2.9% |
| Q2 2026 | $10.94 | +15% |
| Q1 2026 | $10.73 | +14% |
| Q4 2025 | $10.43 | +8.3% |
| Q3 2025 | $9.89 | -0.9% |
| Q2 2025 | $9.51 | -7% |
| Q1 2025 | $9.42 | -9.1% |
| Q4 2024 | $9.63 | -8.5% |
| Q3 2024 | $9.98 | -6.2% |
PFBC earned $10.94 per share over the past year, up 15% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over PFBC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over PFBC on profitability, with a higher operating margin.
PFBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $125.7M | +1.2% |
| Q1 2026 | $120.8M | +1.9% |
| Q4 2025 | $129.3M | +1.6% |
| Q3 2025 | $130.5M | -1.8% |
| Q2 2025 | $124.2M | -5% |
| Q1 2025 | $118.5M | -8.5% |
| Q4 2024 | $127.3M | +2.9% |
| Q3 2024 | $132.9M | +3.4% |
PFBC's revenue grew through 2023 and has held roughly level since: $126M last quarter, up 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 39% | +1.1 points |
| Q1 2026 | 37% | +1 points |
| Q4 2025 | 38% | +4.8 points |
| Q3 2025 | 39% | +3.7 points |
| Q2 2025 | 38% | +1.3 points |
| Q1 2025 | 36% | -0.5 points |
| Q4 2024 | 33% | -7.1 points |
| Q3 2024 | 35% | -6.2 points |
PFBC's operating margin was 39% last quarter, up 1.1 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
PFBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $26.6M | +4.3% |
| Q1 2026 | $44.3M | 0% |
| Q4 2025 | $86.2M | +116% |
| Q3 2025 | $10.8M | -81% |
| Q2 2025 | $25.5M | -0.8% |
| Q1 2025 | $44.3M | +4.7% |
| Q4 2024 | $39.8M | +$41M |
| Q3 2024 | $55.8M | -5.4% |
PFBC has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PFBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -243K shares |
| 1 year | -7.6% | -990K shares |
| 3 years | -17% | -2.5M shares |
| 5 years | -19% | -2.9M shares |
| Available history | -20% | -3M shares |
PFBC has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $101,000 |
| Q1 2026 | $41.4M |
| Q4 2025 | $16.3M |
| Q3 2025 | $6.4M |
| Q2 2025 | $57.2M |
| Q1 2025 | $13.2M |
| Q4 2024 | $6.5M |
| Q3 2024 | $5.4M |
PFBC spent $64M buying back its own shares over the past year, down 22% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
PFBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -4.0x | Net Cash |
| Q4 2024 | -3.2x | Net Cash |
| Q3 2024 | -3.1x | Net Cash |
PFBC has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PFBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 33.4 | Neutral |
PFBC's weekly RSI is 52 (neutral) and its Stochastic is 33 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
PFBC PE vs Financial Services Sector
| Metric | PFBC | Sector median | Relative |
|---|---|---|---|
| PE | 9.5x | 13x | 27% below |
| PE % | 52 | 63 | 11 pts below |
PFBC has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over PFBC on trend strength, trading above more of its moving averages.
PFBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $105.2 | 1.7% below |
| 20 week MA | $105.2 | 1.6% below |
| 50 week MA | $98.4 | 5.1% above |
| 100 week MA | $93.0 | 11% above |
| 200 week MA | $81.5 | 27% above |
PFBC has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 27% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over PFBC on returns for 2026, with the stronger performance.
PFBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.8 | $48.6 | -19% |
| 2021 | $48.6 | $69.7 | +43% |
| 2022 | $69.7 | $75.0 | +7.7% |
| 2023 | $75.0 | $73.1 | -2.7% |
| 2024 | $73.1 | $86.7 | +19% |
| 2025 | $86.7 | $99.0 | +14% |
| 2026 YTD | $99.0 | $103.5 | +4.5% |
PFBC has finished higher in four of the last six years. It's up 4.5% so far in 2026.